[1] Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan [2] Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Center, Taipei, Taiwan.
Oncogene. 2012 Feb 13. doi: 10.1038/onc.2012.29.
Epigenetic modifications are a driving force in carcinogenesis. However, their role in cancer metastasis remains poorly understood. The present study investigated the role of DNA methylation in the cervical cancer metastasis. Here, we report evidence of the overexpression of DNA methyltransferases 3B (DNMT3B) in invasive cervical cancer and of the inhibition of metastasis by DNMT3B interference. Using methyl-DNA immunoprecipitation coupled with microarray analysis, we found that the protein tyrosine phosphatase receptor type R (PTPRR) was silenced through DNMT3B-mediated methylation in the cervical cancer. PTPRR inhibited p44/42 MAPK signaling, the expression of the transcription factor AP1, human papillomavirus (HPV) oncogenes E6/E7 and DNMTs. The methylation status of PTPRR increased in cervical scrapings (n=358) in accordance with disease severity, especially in invasive cancer. Methylation of the PTPRR promoter has an important role in the metastasis and may be a biomarker of invasive cervical cancer.
Oncogene advance online publication, 13 February 2012; doi:10.1038/onc.2012.29.
PMID: 22330137 [PubMed - as supplied by publisher] Source: National Library of Medicine.
